Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 764234, 9 pages
http://dx.doi.org/10.1155/2014/764234
Clinical Study

Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease

1Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China
2Institute & Hospital of Hepatobiliary Surgery, Key Laboratory of Digital Hepatobiliary Surgery of Chinese PLA, Chinese PLA Medical School, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China
3Department of General Surgery, Chengdu First People’s Hospital, Sichuan 610041, China
4Key Laboratory of Transplant Engineering and Immunology of Health Ministry, West China Hospital, Sichuan University, Chengdu, Sichuan 610044, China

Received 20 September 2014; Accepted 18 November 2014; Published 18 December 2014

Academic Editor: Xiao-Feng Yang

Copyright © 2014 Shi-Chun Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Jiang, L. Yan, B. Li et al., “Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin,” American Journal of Transplantation, vol. 10, no. 8, pp. 1861–1869, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Markowitz, P. Martin, A. J. Conrad et al., “Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin,” Hepatology, vol. 28, no. 2, pp. 585–589, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Samuel, R. Muller, G. Alexander et al., “Liver transplantation in European patients with the hepatitis B surface antigen,” The New England Journal of Medicine, vol. 329, no. 25, pp. 1842–1847, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. R. P. Perrillo and A. L. Mason, “Hepatitis B and liver transplantation—problems and promises,” The New England Journal of Medicine, vol. 329, no. 25, pp. 1885–1887, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. E. B. Keefe, “End-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B,” Journal of Medical Virology, vol. 61, no. 3, pp. 403–408, 2000. View at Publisher · View at Google Scholar
  6. C. Trautwein, “Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation,” Journal of Hepatology, vol. 41, no. 3, pp. 362–369, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Sanchez-Fueyo, A. Rimola, L. Grande et al., “Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation,” Hepatology, vol. 31, no. 2, pp. 496–501, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Sanchez-Fueyo, E. Martinez-Bauer, A. Rimola, M. Angelico, D. di Paolo, and G. Tisone, “Hepatitis B vaccination after liver transplantation,” Hepatology, vol. 36, no. 1, pp. 257–259, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Bienzle, M. Günther, R. Neuhaus, and P. Neuhaus, “Successful hepatitis B vaccination in patients who underwent transplantation for hepatitis b virus-related cirrhosis: preliminary results,” Liver Transplantation, vol. 8, no. 6, pp. 562–564, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. U. Bienzle, M. Günther, R. Neuhaus et al., “Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease,” Hepatology, vol. 38, no. 4, pp. 811–819, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. E. A. Arbizu, R. B. Marugan, E. O. Nieto et al., “Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary results,” Transplantation Proceedings, vol. 35, no. 5, pp. 1848–1849, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Angelico, D. Di Paolo, M. O. Trinito et al., “Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis,” Hepatology, vol. 35, no. 1, pp. 176–181, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. C. M. Lo, C. L. Liu, S. C. Chan, G. K. Lau, and S. T. Fan, “Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B,” Journal of Hepatology, vol. 43, no. 2, pp. 283–287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Rosenau, N. Hooman, K. Rifai et al., “Active immunization after liver transplantation for HBV related liver disease: failure to induce HBV specific humoral and cellular immune responses,” Journal of Hepatology, vol. 40, article 6, 2004. View at Google Scholar
  15. J. Rosenau, N. Hooman, J. Hadem et al., “Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation,” Liver Transplantation, vol. 13, no. 3, pp. 367–373, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. P. Cooreman, G. Leroux-Roels, and W. P. Paulij, “Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen,” Journal of Biomedical Science, vol. 8, no. 3, pp. 237–247, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Lai, S. C. Lu, Y. P. Li, J. Zhao, J. Dai, and S. J. Jin, “Detection of titers and replications of HBV DNA in peripheral blood mononuclear cells and bone marrow CD34+ cells in liver transplant recipients receiving prophylactic combined lamivudine and hepatitis B immunoglobulin treatments,” Zhonghua Gan Zang Bing Za Zhi, vol. 15, no. 11, pp. 852–853, 2007 (Chinese). View at Google Scholar
  18. J. Dai, S. C. Lu, L. N. Yan et al., “An analysis of long term prophylaxis of virus recurrence with antiviral treatment in HBV infected liver transplant recipient patients,” Zhonghua Gan Zang Bing Za Zhi, vol. 15, no. 9, pp. 663–666, 2007 (Chinese). View at Google Scholar · View at Scopus
  19. J. Dai, S. C. Lu, L. N. Yan et al., “Investigation on the alteration of hepatitis B virus (HBV) markers in liver allograft of HBV related recipients in perioperative period,” Zhonghua Gan Zang Bing Za Zhi, vol. 12, no. 6, pp. 331–333, 2004 (Chinese). View at Google Scholar
  20. C.-M. Lo, G. K. Lau, S.-C. Chan, S.-T. Fan, and J. Wong, “Efficacy of a pre-S containing vaccine in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B,” American Journal of Transplantation, vol. 7, no. 2, pp. 434–439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Stärkel, M. Stoffel, J. Lerut, and Y. Horsmans, “Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients,” Liver Transplantation, vol. 11, no. 10, pp. 1228–1234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. M. Wen, D. Qu, and S. H. Zhou, “Antigen-antibody complex as therapeutic vaccine for viral hepatitis B,” International Reviews of Immunology, vol. 18, no. 3, pp. 251–258, 1999. View at Publisher · View at Google Scholar · View at Scopus